These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28288474)

  • 1. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
    McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; André T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater J; Valle JW
    J Hepatol; 2020 Nov; 73(5):1109-1117. PubMed ID: 32446715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification, diagnosis, and management of cholangiocarcinoma.
    Razumilava N; Gores GJ
    Clin Gastroenterol Hepatol; 2013 Jan; 11(1):13-21.e1; quiz e3-4. PubMed ID: 22982100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment of advanced or recurrent biliary tract cancer.
    Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
    Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic advances in the management of biliary tract carcinoma].
    Ribiere SC; Léandri C; Guillaumot MA; Brezault C; Coriat R
    Presse Med; 2018 May; 47(5):419-422. PubMed ID: 29622390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics and treatment of cholangiocellular carcinoma].
    Zender L; Malek NP
    Internist (Berl); 2016 Dec; 57(12):1191-1205. PubMed ID: 27822622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant lesions of the extrahepatic biliary system].
    Litchinko A; Peloso A; Toso C; Compagnon P
    Rev Med Suisse; 2022 Jun; 18(786):1210-1217. PubMed ID: 35703864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.
    Pracht M; Le Roux G; Sulpice L; Mesbah H; Manfredi S; Audrain O; Boudjema K; Raoul JL; Boucher E
    Chemotherapy; 2012; 58(2):134-41. PubMed ID: 22572213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocarcinoma: State of the Art.
    Moazzami B; Majidzadeh-A K; Dooghaie-Moghadam A; Eslami P; Razavi-Khorasani N; Iravani S; Khoshdel A; Shahi F; Dashti H; Mehrvar A; Nassiri Toosi M
    J Gastrointest Cancer; 2020 Sep; 51(3):774-781. PubMed ID: 32157571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
    Schweitzer N; Vogel A
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation for cholangiocarcinoma.
    Masuoka HC; Rosen CB
    Clin Liver Dis; 2011 Nov; 15(4):699-715. PubMed ID: 22032524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
    Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience.
    Trikalinos NA; Zhou A; Doyle MBM; Fowler KJ; Morton A; Vachharajani N; Amin M; Keller JW; Chapman WC; Brunt EM; Tan BR
    J Natl Compr Canc Netw; 2018 Oct; 16(10):1193-1199. PubMed ID: 30323089
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma: A single-center study.
    Choe JW; Kim HJ; Kim JS
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):153-156. PubMed ID: 31974040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.